23 related articles for article (PubMed ID: 38716596)
1. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia.
Xiao F; Guo H; Yan X; Qi M; Zhang J
Transpl Immunol; 2024 Jun; 84():102037. PubMed ID: 38499049
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Copelan EA; Avalos BR; Ahn KW; Zhu X; Gale RP; Grunwald MR; Hamadani M; Hamilton BK; Hale GA; Marks DI; Waller EK; Savani BN; Costa LJ; Ramanathan M; Cahn JY; Khoury HJ; Weisdorf DJ; Inamoto Y; Kamble RT; Schouten HC; Wirk B; Litzow MR; Aljurf MD; van Besien KW; Ustun C; Bolwell BJ; Bredeson CN; Fasan O; Ghosh N; Horowitz MM; Arora M; Szer J; Loren AW; Alyea EP; Cortes J; Maziarz RT; Kalaycio ME; Saber W
Biol Blood Marrow Transplant; 2015 Mar; 21(3):552-8. PubMed ID: 25528388
[TBL] [Abstract][Full Text] [Related]
4. [Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia].
Wu Y; Tang BL; Song KD; Sun GY; Pan TZ; Huang AJ; Yan BB; Zhu XY
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):68-73. PubMed ID: 38527841
[No Abstract] [Full Text] [Related]
5. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
Holter-Chakrabarty JL; Pierson N; Zhang MJ; Zhu X; Akpek G; Aljurf MD; Artz AS; Baron F; Bredeson CN; Dvorak CC; Epstein RB; Lazarus HM; Olsson RF; Selby GB; Williams KM; Cooke KR; Pasquini MC; McCarthy PL
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1251-7. PubMed ID: 25840335
[TBL] [Abstract][Full Text] [Related]
6. Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia.
Tracey J; Zhang MJ; Thiel E; Sobocinski KA; Eapen M
Biol Blood Marrow Transplant; 2013 Feb; 19(2):255-9. PubMed ID: 23041605
[TBL] [Abstract][Full Text] [Related]
7. Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group.
Esiashvili N; Lu X; Ulin K; Laurie F; Kessel S; Kalapurakal JA; Merchant TE; Followill DS; Sathiaseelan V; Schmitter MK; Devidas M; Chen Y; Wall DA; Brown PA; Hunger SP; Grupp SA; Pulsipher MA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):513-521. PubMed ID: 30807822
[TBL] [Abstract][Full Text] [Related]
8. The outcome of relapsed childhood acute lymphoblastic leukemia after allogeneic hematopoietic stem-cell transplantations: A single-center experience.
Aygüneş U; Karagün BŞ; Şaşmaz I; Antmen AB
Clin Transplant; 2024 May; 38(5):e15366. PubMed ID: 38775798
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
[TBL] [Abstract][Full Text] [Related]
10. Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.
Nichols-Vinueza DX; Parta M; Shah NN; Cuellar-Rodriguez JM; Bauer TR; West RR; Hsu AP; Calvo KR; Steinberg SM; Notarangelo LD; Holland SM; Hickstein DD
Br J Haematol; 2022 Jan; 196(1):169-178. PubMed ID: 34580862
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of tacrolimus blood concentrations early after allogeneic hematopoietic stem cell transplantation.
Kubo H; Imataki O; Fukumoto T; Ishida T; Kubo YH; Yoshida S; Uemura M; Fujita H; Kadowaki N
Cytotherapy; 2024 May; 26(5):472-481. PubMed ID: 38456854
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 14 patients aged ≤ 50 years with high-risk multiple myeloma treated with allogeneic hematopoietic stem cell transplantation].
Pan P; Wang JL; Zhai WH; Ma QL; Yang DL; Feng SZ; Han MZ; Pang AM; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):28-34. PubMed ID: 38527835
[No Abstract] [Full Text] [Related]
13. Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party.
El Cheikh J; Ngoya M; Galimard JE; Reményi P; Kulagin A; Aljurf M; Mousavi A; Wu D; Ozcelik T; Salmenniemi U; Castilla-Llorente C; Socie G; Helbig G; Schroeder T; Sakellari I; Rambaldi A; Burt R; Busca A; Balsat M; Stelljes M; Brissot E; Giebel S; Peric Z; Nagler A; Bazarbachi A; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Jun; ():. PubMed ID: 38834689
[TBL] [Abstract][Full Text] [Related]
14. Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Prete A; Lanino E; Saglio F; Biffi A; Calore E; Faraci M; Rondelli R; Favre C; Zecca M; Casazza G; Porta F; Luksch R; Cesaro S; Rabusin M; Parasole R; Mura RM; Lo Nigro L; Leardini D; Pagliara D; Locatelli F; Fagioli F;
Transplant Cell Ther; 2024 May; 30(5):530.e1-530.e8. PubMed ID: 38460729
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma.
Bachanova V; Shanley R; Malik F; Chauhan L; Lamba V; Weisdorf DJ; Burns LJ; Lamba JK
Biol Blood Marrow Transplant; 2015 May; 21(5):944-8. PubMed ID: 25677220
[TBL] [Abstract][Full Text] [Related]
16. Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.
Steiner N; Massoud R; Klyuchnikov E; Gagelmann N; Richter J; Niederwieser C; Rathje K; Urbanowicz T; Kunte A; Engelmann J; Ihne C; Lastovytska I; Lindhauer C; Marquard F; Reichard M; Ryzhkova A; Sabauri R; Schäfersküpper M; Seyedi N; Kalogeropoulos G; Heidenreich S; Rudolph I; Zeck G; Janson D; Wolschke C; Ayuk F; Kröger N
Bone Marrow Transplant; 2024 Jun; ():. PubMed ID: 38877098
[TBL] [Abstract][Full Text] [Related]
17. Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
Esquirol A; Pascual MJ; Kwon M; Pérez A; Parody R; Ferra C; Garcia Cadenas I; Herruzo B; Dorado N; Hernani R; Sanchez-Ortega I; Torrent A; Sierra J; Martino R;
Bone Marrow Transplant; 2021 Oct; 56(10):2432-2444. PubMed ID: 34059802
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience.
Pérez-Torres Lobato M; Benitez-Carabante MI; Alonso L; Torrents S; Castillo Flores N; Uria Oficialdegui ML; Panesso M; Alonso-Martínez C; Oliveras M; Renedo-Miró B; Vives J; Diaz-de-Heredia C
Front Pediatr; 2024; 12():1375493. PubMed ID: 38783918
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation.
Wen Q; Guo Z; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Sun YQ; Huang XJ; Mo XD
Sci Rep; 2024 May; 14(1):11778. PubMed ID: 38782966
[TBL] [Abstract][Full Text] [Related]
20. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation.
Gress RE; Miller JS; Battiwalla M; Bishop MR; Giralt SA; Hardy NM; Kröger N; Wayne AS; Landau DA; Wu CJ
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1537-45. PubMed ID: 24018395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
